Total revenues in the second quarter were $39.8 billion, up 5.9% year over year.
Total net earnings in the second quarter were nearly $1.1 billion, up 8.6% since the same period last year.
The company reaffirmed its year-end adjusted EPS guidance to at least $6.80.
The company’s medical loss ratio was 87.6% in the second quarter and 87% during the same period last year. Days claims payable were 54 in the second quarter, compared to 52 a year ago.
As of June 30, Centene’s total membership stands at nearly 28.5 million. Medicaid membership has fallen to 13.1 million, decreasing 18.2% year over year. There are 4.4 million exchange members, 426,000 commercial group members, 1.1 million Medicare Advantage and supplement members, and 6.6 million Medicare prescription drug plans.
At the Becker's 5th Annual Fall Payer Issues Roundtable, taking place November 2–3 in Chicago, payer executives and healthcare leaders will come together to discuss value-based care, regulatory changes, cost management strategies and innovations shaping the future of payer-provider collaboration. Apply for complimentary registration now.
